UNSPSC 51113602: Oprelvekin

This classification denotes a therapeutic interleukin with the molecular formula C854H1411N253O235S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) HM5641GA6F, more generally known as oprelvekin. European Medicines Agency schedules oprelvekin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14704MIG. The term OPRELVEKIN is an International Non-Proprietary Name or INN. see World Health Organization INN reference publication, Volume 11, no. 3 1997, list 38.

UNSPSC 51113602 Oprelvekin is a Commodity code covering a specific pharmaceutical product — a thrombopoietin receptor agonist used to stimulate platelet production in patients undergoing chemotherapy. State and local governments procure this drug through health departments, public hospitals, county clinics, and other health-system entities as part of oncology and hematology treatment protocols. The product is purchased in clinical settings where platelet counts require management during cancer care, and procurement typically occurs through standing contracts with pharmaceutical wholesalers or direct agreements with manufacturers, often leveraging group purchasing arrangements or state formulary programs.

The source provides no recent state or local contract opportunities tagged to this code, so current market activity cannot be characterized by issuing body, geographic spread, or representative solicitation.